课题基金 / 基金详情

PACTG P-1045

PACTG P-1045
PACTG P-1045
批准号:
7375353
负责人:
Sharon A Nachman
金额:
$1.8万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-12-01 至 2006-11-30
关键词:

项目摘要

项目成果

Sharon A Nachman的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to look at how the body breaks down blood sugar, the amounts of fat, proteins and other substances in the blood, the amount of body fat and fat distribution and how solid bones are in: 1. HIV-infected children compared to HIV-uninfected children 2. HIV-infected and uninfected children at different stages of sexual development 3. HIV-infected children taking a class of anti-HIV drugs called protease inhibitors compared to HIV-infected children not taking PIs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
LOC-IMPAACT Leadership GroupPharmacokinetics and Safety of Remdesivir for Treatment of COVID-19 in Pregnant Women in the US
  • 批准号:
    10174121
  • 项目类别:
  • 资助金额:
    $94.26万
  • 财政年份:
    2020
  • 负责人:
    Sharon A Nachman
  • 依托单位:
SURVEILLANCE MONITORING FOR ART TOXICITIES
CLINICAL TRIAL: PHASE I/II STUDY OF SAFETY AND IMMUNOGENICITY OF QUADRIVALENT ME
CLINICAL TRIAL: PHASE I/II MULTICENTER,OPEN LABEL,NONCOMPARITIVE STUDY OF HIV AF
国内基金
海外基金
结核分枝杆菌毒素-抗毒素系统(TA)Rv1045-1044的结构和功能研究